Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer

Iodine-resistant cancers account for the vast majority of thyroid related mortality and, until recently, there were limited therapeutic options. However, over the last decade our understanding of the molecular foundation of thyroid function and carcinogenesis has driven the development of many novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Fullmer, Tanner, Cabanillas, Maria E., Zafereo, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321684/
https://www.ncbi.nlm.nih.gov/pubmed/34335481
http://dx.doi.org/10.3389/fendo.2021.720723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321684/
https://www.ncbi.nlm.nih.gov/pubmed/34335481
http://dx.doi.org/10.3389/fendo.2021.720723

Ejemplares similares